The role of photodynamic therapy in the esophagus.
暂无分享,去创建一个
[1] Stephen G Bown,et al. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. , 2005, Gastrointestinal endoscopy.
[2] B. Overholt,et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. , 2009, Gastroenterology.
[3] W S Payne,et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.
[4] B. Overholt,et al. Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment. , 2008, Anticancer research.
[5] Kenneth K Wang,et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. , 2001, Gastrointestinal endoscopy.
[6] Prateek Sharma,et al. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. , 2002 .
[7] M. Mino‐Kenudson,et al. Buried Barrett's Epithelium Following Photodynamic Therapy Shows Reduced Crypt Proliferation and Absence of DNA Content Abnormalities , 2008, The American Journal of Gastroenterology.
[8] C J Stoddard,et al. Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.
[9] C. Foroulis,et al. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] B. Overholt,et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.
[11] B. Reid,et al. p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.
[12] M. Wallace,et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.
[13] Victor X D Yang,et al. Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barrett's esophagus. , 2007, Gastrointestinal endoscopy.
[14] T. Stephenson,et al. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus. , 2000, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[15] V. Drory,et al. Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy , 2005, Muscle & nerve.
[16] H. Bergh. On the evolution of some endoscopic light delivery systems for photodynamic therapy , 1998 .
[17] A. May,et al. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. , 1999, Endoscopy.
[18] M. Reed,et al. The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.
[19] A. Zinsmeister,et al. Prevalence of columnar-lined (Barrett's) esophagus , 1990 .
[20] H. Wolfsen,et al. Photodynamic Therapy for Barrett’s Esophagus and High Grade Dysplasia: Results of a Patient Satisfaction Survey , 2002, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.
[21] Q. Peng,et al. Photodynamic Therapy , 1988, Methods in Molecular Biology.
[22] J. Luketich,et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. , 2003, The Annals of thoracic surgery.
[23] D. Kessel,et al. Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.
[24] Navtej S Buttar,et al. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. , 2007, Gastrointestinal endoscopy.
[25] E. G. Hahn,et al. Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5‐aminolevulinic acid , 1999, Cancer.
[26] P. Siersema. Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. , 2005, Gastrointestinal endoscopy.
[27] Hector Nava,et al. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy , 2005, Cancer Chemotherapy and Pharmacology.
[28] Kenneth K Wang,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.
[29] N. J. Brown,et al. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus , 2004, Surgical Endoscopy And Other Interventional Techniques.
[30] T. Dougherty. An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.
[31] M. Raimondo,et al. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. , 2002, Mayo Clinic proceedings.
[32] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.
[33] L. Gossner,et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .
[34] H. Wolfsen,et al. Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms , 2006, The American Journal of Gastroenterology.
[35] L. Gossner,et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.
[36] M. Rugge,et al. The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[37] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[38] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[39] E. Ellison,et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. , 1996, The Annals of thoracic surgery.
[40] Patricia L. Blount,et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.
[41] H. Wolfsen. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. , 2005, Gastrointestinal endoscopy.
[42] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[43] Patricia L. Blount,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .
[44] Mary N. Phan,et al. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment , 2005 .
[45] Masoud Panjehpour,et al. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.
[46] T. Stephenson,et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. , 2003, Endoscopy.
[47] Kenneth K Wang,et al. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. , 2000, Gastrointestinal endoscopy.
[48] S. Bown,et al. New photosensitizers for photodynamic therapy in gastroenterology. , 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[49] T. Stephenson,et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.
[50] H. Wolfsen,et al. Photodynamic therapy for esophageal diseases: a clinical update. , 2003, Endoscopy.
[51] B. Overholt,et al. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. , 2000, Gastrointestinal endoscopy clinics of North America.
[52] N. Nishioka,et al. Cost-Effectiveness of Photodynamic Therapy for Treatment of Barrett's Esophagus with High Grade Dysplasia , 2003, Digestive Diseases and Sciences.
[53] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[54] M Dietel,et al. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. , 2002, Endoscopy.
[55] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[56] H. Barr,et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. , 1999, Journal of photochemistry and photobiology. B, Biology.
[57] B. Reid,et al. Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.
[58] N. Nishioka,et al. Patient predictors of esophageal stricture development after photodynamic therapy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[59] P. Monnier,et al. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy , 1996, Lasers in surgery and medicine.
[60] Kenneth K Wang,et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[61] Bergein F Overholt,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.
[62] H. Bergh,et al. Rapid Communication: Stability of the Fluorescence Measurement of Foscan® in the Normal Human Oral Cavity as an Indicator of its Content in Early Cancers of the Esophagus and the Bronchi , 1999, Photochemistry and photobiology.
[63] P. Fockens,et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. , 2005, Endoscopy.
[64] Kenneth K Wang,et al. Current status of photodynamic therapy of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.
[65] Arjun G Yodh,et al. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. , 2003, Journal of biomedical optics.
[66] J. Tokar,et al. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. , 2007, Seminars in radiation oncology.
[67] H. Wolfsen. Endoluminal therapy for Barrett's esophagus. , 2007, Gastrointestinal endoscopy clinics of North America.
[68] H. S. de Bruijn,et al. Monitoring In Situ Dosimetry and Protoporphyrin IX Fluorescence Photobleaching in the Normal Rat Esophagus During 5-Aminolevulinic Acid Photodynamic Therapy¶ , 2003 .
[69] K. Ragunath,et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: A randomized prospective trial assessing efficacy and cost-effectiveness , 2005, Scandinavian journal of gastroenterology.
[70] L. Gossner,et al. Long Term Results of PDT for Early Neoplasia in Barrett's Esophagus , 2004 .
[71] Thomas J. Dougherty,et al. Basic principles of photodynamic therapy , 2001 .
[72] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[73] Hiroshi Mashimo,et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.
[74] M. Guelrud,et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.
[75] J. Devière,et al. Long-term Follow-Up and Factors Predictive of Recurrence in Barrett's Esophagus Treated by Argon Plasma Coagulation and Acid Suppression , 2002, Endoscopy.
[76] G. Lapertosa,et al. Barrett's esophagus: an update. , 2003, Critical reviews in oncology/hematology.
[77] R. Sampliner. Prevention of Adenocarcinoma by Reversing Barrett’s Esophagus with Mucosal Ablation , 2003, World Journal of Surgery.
[78] H. Barr,et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.
[79] Kenneth K Wang,et al. Photodynamic therapy in Barrett's esophagus. , 2003, Gastrointestinal endoscopy clinics of North America.
[80] M. Zenker. Argon plasma coagulation , 2008, GMS Krankenhaushygiene interdisziplinar.
[81] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.
[82] D J Ballard,et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.
[83] M. V. Scott,et al. Pilot Study on Light Dosimetry Variables for Photodynamic Therapy of Barrett's Esophagus with High-Grade Dysplasia , 2009, Clinical Cancer Research.
[84] C. Hadjur,et al. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. , 1997, British Journal of Cancer.
[85] Herbert C Wolfsen,et al. Present Status of Photodynamic Therapy for High-Grade Dysplasia in Barrett's Esophagus , 2005, Journal of clinical gastroenterology.
[86] G. Bourg-Heckly,et al. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. , 2004, Gastrointestinal endoscopy.
[87] A. Radu,et al. Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model. , 2003, Gastrointestinal endoscopy.
[88] J. Luketich,et al. Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer , 2007, Annals of Surgical Oncology.
[89] M Panjehpour,et al. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. , 1993, Gastrointestinal endoscopy.
[90] P. Grosjean,et al. Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study. , 2001, Journal of photochemistry and photobiology. B, Biology.
[91] H. Wolfsen. Endoprevention of esophageal cancer: endoscopic ablation of Barrett’s metaplasia and dysplasia , 2005, Expert review of medical devices.
[92] B. Overholt,et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation , 2000, American Journal of Gastroenterology.
[93] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[94] H. Bergh,et al. Optimization of the Diameter of a Radial Irradiation Device for Photodynamic Therapy in the Esophagus , 2002, Endoscopy.
[95] B. Overholt,et al. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis , 2003, Gut.
[96] B. Overholt,et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.
[97] N. Krasner,et al. Photodynamic Therapy (PDT) for Oesophageal Dysplasia and Early Carcinoma with mTHPC (m-Tetrahydroxyphenyl Chlorin): A Preliminary Study , 2002, Lasers in Medical Science.
[98] C. Mosse,et al. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus , 2008, Lasers in Medical Science.
[99] H. Wolfsen,et al. Photodynamic Therapy for Dysplastic Barrett's Esophagus and Mucosal Adenocarcinoma , 2004 .
[100] L. Gossner,et al. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. , 2005, Endoscopy.
[101] E. Steyerberg,et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.
[102] L. Gossner,et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. , 2002, Endoscopy.
[103] A. Zinsmeister,et al. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus , 2008, Cancer.